These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33504081)

  • 1. Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project.
    Carmona A; Muñoz-Quiles C; Stuurman A; Descamps A; Mira-Iglesias A; Torcel-Pagnon L; Díez-Domingo J
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33504081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
    Stuurman AL; Carmona A; Biccler J; Descamps A; Levi M; Baum U; Mira-Iglesias A; Bellino S; Hoang U; de Lusignan S; Bonaiuti R; Lina B; Rizzo C; Nohynek H; Díez-Domingo J;
    Front Public Health; 2023; 11():1195409. PubMed ID: 37546295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Stuurman AL; Biccler J; Carmona A; Descamps A; Díez-Domingo J; Muñoz Quiles C; Nohynek H; Rizzo C; Riera-Montes M;
    Vaccine; 2021 Jun; 39(29):3964-3973. PubMed ID: 34092427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19.
    Stuurman AL; Bollaerts K; Alexandridou M; Biccler J; Díez Domingo J; Nohynek H; Rizzo C; Turunen T; Riera-Montes M;
    Vaccine; 2020 Sep; 38(41):6455-6463. PubMed ID: 32778474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative.
    Díez-Domingo J; Torcel-Pagnon L; Carmona A; Launay O; Dos Santos G; Rizzo C; Haag M; Stuurman A; Nauta J; Vannacci A; de Lusignan S; Del Rey E; Levi M; Lina B; Bellino S; Nye S; Neels P; Nohynek H; Mahé C;
    Expert Rev Vaccines; 2022 Dec; 21(12):1701-1710. PubMed ID: 36261918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project.
    Stuurman AL; Levi M; Beutels P; Bricout H; Descamps A; Dos Santos G; McGovern I; Mira-Iglesias A; Nauta J; Torcel-Pagnon L; Biccler J;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13087. PubMed ID: 36550627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination strategies for 2020-21 in the context of COVID-19.
    Wang X; Kulkarni D; Dozier M; Hartnup K; Paget J; Campbell H; Nair H;
    J Glob Health; 2020 Dec; 10(2):021102. PubMed ID: 33312512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
    Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
    Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States.
    Valenciano M; Ciancio B; Moren A;
    Euro Surveill; 2008 Oct; 13(43):. PubMed ID: 18947520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Thompson MG; Kwong JC; Regan AK; Katz MA; Drews SJ; Azziz-Baumgartner E; Klein NP; Chung H; Effler PV; Feldman BS; Simmonds K; Wyant BE; Dawood FS; Jackson ML; Fell DB; Levy A; Barda N; Svenson LW; Fink RV; Ball SW; Naleway A;
    Clin Infect Dis; 2019 Apr; 68(9):1444-1453. PubMed ID: 30307490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 pandemic on flu vaccine uptake in healthcare workers in Europe: a systematic review and meta-analysis.
    Bianchi FP; Cuscianna E; Rizzi D; Signorile N; Daleno A; Migliore G; Tafuri S
    Expert Rev Vaccines; 2023; 22(1):777-784. PubMed ID: 37605528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.